Published in Drug Des Devel Ther on March 09, 2017
Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet (1999) 3.61
Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (2007) 1.56
Safety and pharmacology of oseltamivir in clinical use. Drug Saf (2003) 1.56
Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs. Molecules (2008) 1.52
Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid. Clin Pharmacokinet (1989) 1.39
The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacotherapy (2013) 1.37
Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation. Nephrol Dial Transplant (2003) 1.34
Oseltamivir: a review of its use in influenza. Drugs (2001) 1.34
Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations. J Antimicrob Chemother (2010) 1.31
Dexamethasone differentially regulates expression of carboxylesterase genes in humans and rats. Drug Metab Dispos (2000) 1.26
Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants. Drug Metab Dispos (2008) 1.07
Carboxylesterase inhibitors. Expert Opin Ther Pat (2011) 1.06
Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide. J Pharmacol Exp Ther (2005) 1.03
Effect of corticosteroids on blood salicylate concentration. JAMA (1965) 1.01
Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice. Eur Respir J (2009) 1.00
Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid. Br J Clin Pharmacol (1986) 0.97
Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet (1990) 0.96
The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect. Drug Metabol Drug Interact (2014) 0.95
Different inhibitory effects in rat and human carboxylesterases. Drug Metab Dispos (2009) 0.94
Dexamethasone suppresses the expression of multiple rat carboxylesterases through transcriptional repression: evidence for an involvement of the glucocorticoid receptor. Toxicology (2008) 0.91
Dexamethasone-induced methylprednisolone hemisuccinate hydrolase: its identification as a member of the rat carboxylesterase 2 family and its unique existence in plasma. Biochem Pharmacol (2005) 0.87
Glucocorticosteroid in treatment of severe pneumonia. Mediators Inflamm (2013) 0.79
Purification and characterization of glucocorticoid-inducible steroid esterase in rat hepatic microsomes. Biochem Pharmacol (1992) 0.78
A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects. Drug Des Devel Ther (2015) 0.78
Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers. Drug Des Devel Ther (2014) 0.75
The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans. PLoS One (2017) 0.75